(Q46845177)

25 December 2017

http://europepmc.org/abstract/MED/16341049

title

Alemtuzumab induces caspase-independent cell death in human chronic lymphocytic leukemia cells through a lipid raft-dependent mechanism (English)

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

0 references

1 reference

1 reference

chronic lymphocytic leukemia

1 reference

1 reference

A P Mone

1

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

C Cheney

2

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

A L Banks

3

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

S Tridandapani

4

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

N Mehter

5

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

S Guster

6

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

T Lin

7

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

C F Eisenbeis

8

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

D C Young

9

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

J C Byrd

10

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

publication date

1 February 2006

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

published in

Leukemia

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

volume

20

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

issue

2

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

page(s)

272-279

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

cites work

Recognition of CD52 allelic gene products by CAMPATH-1H antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

The CD52 antigen and development of the CAMPATH antibodies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

The CAMPATH-1 antigen (CDw52)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Differential CD52 expression by distinct myeloid dendritic cell subsets: implications for alemtuzumab activity at the level of antigen presentation in allogeneic graft-host interactions in transplantation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

The glycosylphosphatidylinositol-anchored lymphocyte antigen CDw52 is associated with the epididymal maturation of human spermatozoa

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Levels of expression of CD52 in normal and leukemic B and T cells: correlation with in vivo therapeutic responses to Campath-1H

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

REMISSION INDUCTION IN NON-HODGKIN LYMPHOMA WITH RESHAPED HUMAN MONOCLONAL ANTIBODY CAMPATH-1H

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Treatment of T-cell prolymphocytic leukemia with human CD52 antibody

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Phase II multicenter study of human CD52 antibody in previously treated chronic lymphocytic leukemia. European Study Group of CAMPATH-1H Treatment in Chronic Lymphocytic Leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Humanized monoclonal antibody CAMPATH-1H: myeloma cell expression of genomic constructs, nucleotide sequence of cDNA constructs and comparison of effector mechanisms of myeloma and Chinese hamster ovary cell-derived material

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Efficient complement-mediated lysis of cells containing the CAMPATH-1 (CDw52) antigen

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Cross-linking of the CAMPATH-1 antigen (CD52) triggers activation of normal human T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Cross-linking of the CAMPATH-1 antigen (CD52) mediates growth inhibition in human B- and T-lymphoma cell lines, and subsequent emergence of CD52-deficient cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Alemtuzumab (CAMPATH 1H) does not kill chronic lymphocytic leukemia cells in serum free medium

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Clustered CD20 induced apoptosis: src-family kinase, the proximal regulator of tyrosine phosphorylation, calcium influx, and caspase 3-dependent apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

The chimeric anti-CD20 antibody rituximab induces apoptosis in B-cell chronic lymphocytic leukemia cells through a p38 mitogen activated protein-kinase-dependent mechanism

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

The mechanism of tumor cell clearance by rituximab in vivo in patients with B-cell chronic lymphocytic leukemia: evidence of caspase activation and apoptosis induction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

CD47 ligation induces caspase-independent cell death in chronic lymphocytic leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Fully human, HLA-DR-specific monoclonal antibodies efficiently induce programmed death of malignant lymphoid cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Hu1D10 induces apoptosis concurrent with activation of the AKT survival pathway in human chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

CD24 induces apoptosis in human B cells via the glycolipid-enriched membrane domains/rafts-mediated signaling system

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Blood donor leukocyte reduction filters as a source of human B lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

KRN5500: a novel therapeutic agent with in vitro activity against human B-cell chronic lymphocytic leukemia cells mediates cytotoxicity via the intrinsic pathway of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Lipid rafts, major histocompatibility complex molecules, and immune regulation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Clusters of glycolipid and glycosylphosphatidylinositol-anchored proteins in lymphoid cells: accumulation of actin regulated by local tyrosine phosphorylation

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Lipid domain structure of the plasma membrane revealed by patching of membrane components

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Role of membrane gangliosides in the binding and action of bacterial toxins.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

A role for lipid rafts in B cell antigen receptor signaling and antigen targeting

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Aggregation of lipid rafts accompanies signaling via the T cell antigen receptor

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Dynamic association of CD45 with detergent-insoluble microdomains in T lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Fc gamma RIIB1/SHIP-mediated inhibitory signaling in B cells involves lipid rafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

The state of lipid rafts: from model membranes to cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Lipid rafts: elusive or illusive?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Functional rafts in cell membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Functions of lipid rafts in biological membranes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Direct visualization of redistribution and capping of fluorescent gangliosides on lymphocytes

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Capping of cholera toxin-ganglioside GM1 complexes on mouse lymphocytes is accompanied by co-capping of alpha-actinin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Altered membrane-associated functions in chronic lymphocytic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Cholesterol is required for surface transport of influenza virus hemagglutinin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Cellular cholesterol efflux mediated by cyclodextrins

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Lymphocyte programmed cell death is mediated via HLA class II DR.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Mechanisms of CD47-induced caspase-independent cell death in normal and leukemic cells: link between phosphatidylserine exposure and cytoskeleton organization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

CD20-mediated apoptosis: signalling through lipid rafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Rafts: a simple way to control apoptosis by subcellular redistribution

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Store-operated cation entry mediated by CD20 in membrane rafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Complement-mediated lysis by anti-CD20 mAb correlates with segregation into lipid rafts

1 reference

https://api.crossref.org/works/10.1038%2FSJ.LEU.2404014

7 January 2021

Identifiers

DOI

10.1038/SJ.LEU.2404014

1 reference

25 December 2017

http://europepmc.org/abstract/MED/16341049

1 reference

25 December 2017